Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening.

Clinical chemistry and laboratory medicine - 1 Jan 2006

Andreassi Maria Grazia, Botto Nicoletta, Maffei Silvia

Abstract excerpt

Venous thromboembolism is a well-known complication of oral contraception and hormonal replacement therapy. Inherited thrombophilia is viewed as an important determinant in modulating the effects of estrogens on thrombotic risk. An increasing number of kits for thrombophilic mutations [factor V Leiden, G20210A prothrombin and methylenetetrahydrofolate reductase (MTHFR) C677T genes] are becoming commercially...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contraceptives, Oral
Share to Estrogens
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hormone Replacement Therapy

Share to Hormones

Share to Mass Screening

Share to Prothrombin

Share to Thrombosis

Source

Identifiers

PMID: 16681418
DOI: 10.1515/CCLM.2006.103

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening.PMID 16681418Read ↗

Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: implications for hormone replacement therapy.Semantic proximity Read ↗

Thrombophilias--practical implications and testing caveats.Semantic proximity Read ↗

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.Semantic proximity Read ↗

Management of inherited thrombophilia: guide for genetics professionals.Semantic proximity Read ↗

Molecular diagnostics of inherited thrombosis.Semantic proximity Read ↗

Screening for inherited thrombophilia: indications and therapeutic implications.Semantic proximity Read ↗

Role of the geneticist in testing and counseling for inherited thrombophilia.Semantic proximity Read ↗

Genetic testing for thrombophilia mutations.Semantic proximity Read ↗

Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories.Semantic proximity Read ↗

Evidence-based indications for thrombophilia screening.Semantic proximity Read ↗

Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relativesSemantic proximity Read ↗

Inherited thrombophilia: an update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.